Author

Lie‐Ju Hwang

Observed name: Lie-Ju Hwang

Observed institutions: University of Hawaiʻi at Mānoa, Kuakini Medical Center, University of Massachusetts Chan Medical School, Pfizer (United States), University of Virginia Health System, National Heart, Lung, and Blood Institute, IQVIA (United States), University of Virginia Medical Center, Stanford Medicine, University of Virginia, Stanford University

OpenAlex ID: A5110189532

Combined Effects of HDL Cholesterol, Triglyceride, and Total Cholesterol Concentrations on 18-Year Risk of Atherosclerotic Disease

1995 · Cecil M. Burchfiel, Ami Laws, et al. · Circulation · 78

Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis

2019 · Christina Charles‐Schoeman, Ryan DeMasi, et al. · Arthritis & Rheumatology · 76

PDF

Effects of antifibrinolytic agents on the life span of fibrin sealant

1992 · Catherine M. Pipan, William P. Glasheen, et al. · Journal of Surgical Research · 64

Incidence and predictors of diabetes in Japanese-American men the Honolulu Heart Program

1995 · Cecil M. Burchfiel, J.David Curb, et al. · Annals of Epidemiology · 54

Characteristics associated with rapid decline in forced expiratory volume

1996 · Cecil M. Burchfiel, Ellen B. Marcus, et al. · Annals of Epidemiology · 51

Value and limitations of current methods of evaluating patients presenting to the emergency room with cardiac-related symptoms for determining long-term prognosis

1992 · Flordeliza S. Villanueva, Peter J. Sabia, et al. · The American Journal of Cardiology · 44

Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: Clinical associations

2014 · Neeraj Dhaun, Jean-Luc Vachiery, et al. · The Journal of Heart and Lung Transplantation · 38

Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension

2011 · Julio Sandoval, Adam Torbicki, et al. · Pulmonary Pharmacology & Therapeutics · 37

Inter-visit Intraocular Pressure Range: An Alternative Parameter for Assessing Intraocular Pressure Control in Clinical Trials

2008 · Rohit Varma, Lie-Ju Hwang, et al. · American Journal of Ophthalmology · 33

Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis

2018 · Zhan-Guo Li, Yi Liu, et al. · Chinese Medical Journal · 32

Sildenafil improves renal function in patients with pulmonary arterial hypertension

2015 · David J. Webb, Jean‐Luc Vachiery, et al. · British Journal of Clinical Pharmacology · 31

PDF

To What Extent Do Cardiovascular Risk Factor Values Measured in Elderly Men Represent Their Midlife Values Measured 25 Years Earlier? A Preliminary Report and Commentary From the Honolulu Heart Program

1994 · Richard Benfante, Lie-Ju Hwang, et al. · American Journal of Epidemiology · 29

The Role of Benzalkonium Chloride in the Occurrence of Punctate Keratitis: A Meta-Analysis of Randomized, Controlled Clinical Trials

2010 · Stefan Trocme, Lie-Ju Hwang, et al. · Annals of Pharmacotherapy · 20

Assessment of measurement properties of peak VO2in children with pulmonary arterial hypertension

2012 · Joseph C Cappelleri, Lie-Ju Hwang, et al. · BMC Pulmonary Medicine · 11

PDF

Assessing the Efficacy of Latanoprost vs Timolol Using an Alternate Efficacy Parameter: The Intervisit Intraocular Pressure Range

2009 · Rohit Varma, Lie-Ju Hwang, et al. · American Journal of Ophthalmology · 11

[8] Impact of variance function estimation in regression and calibration

1994 · Lie-Ju Hwang · Methods in enzymology on CD-ROM/Methods in enzymology · 7

Incidence of subdural hematoma in patients with pulmonary arterial hypertension (PAH) in two randomized controlled clinical trials

2012 · Gérald Simonneau, Lie‐Ju Hwang, et al. · European Respiratory Journal · 5

Assessment Of Measurement Properties Of Peak VO2 In Children With Pulmonary Arterial Hypertension

2010 · Joseph C. Cappelleri, Lie-Ju Hwang, et al. · American Journal of Respiratory and Critical Care Medicine · 2

Relationship Between Baseline Pulmonary Capillary Wedge Pressure And Response To Sildenafil Treatment In Pulmonary Arterial Hypertension

2012 · Hunter Champion, Michael Mathier, et al. · American Journal of Respiratory and Critical Care Medicine · 1

Sildenafil (SIL) reduces serum creatinine (SCr) in patients with pulmonary arterial hypertension (PAH): Relationship to clinical outcomes

2011 · David Webb, Jean-Luc Vachiery, et al. · European Respiratory Journal · 1

Sitaxentan Reduces Serum Uric Acid In Patients With Pulmonary Arterial Hypertension: Relationship To Exercise Capacity, Clinical Worsening And Survival

2011 · Jean-Luc Vachiery, Raymond L. Benza, et al. · American Journal of Respiratory and Critical Care Medicine · 1

The Effect Of Sitaxentan On Exercise Capacity, Hemodynamic Function, And Health-Related Quality Of Life Across Who Functional Class In Adults With Pulmonary Arterial Hypertension

2011 · Marko A. Mychaskiw, Lie-Ju Hwang, et al. · American Journal of Respiratory and Critical Care Medicine · 1

Physical Functioning, Six-Minute Walk Distance, and Pulmonary Vascular Resistance in Adult Patients With Pulmonary Arterial Hypertension Treated With Sildenafil: Examining the Distributions of Outcomes

2010 · Joseph C. Cappelleri, Marko A. Mychaskiw, et al. · CHEST Journal · 1

Relationship Between Pulmonary Vascular Resistance and Physical Functioning in Two Randomized Controlled Trials of Adult Patients With Pulmonary Arterial Hypertension, Including Those With Associated Connective Tissue Disease

2010 · Marko A. Mychaskiw, Jack Mardekian, et al. · CHEST Journal · 1

Evaluation Of Sildenafil Treatment On Functional Health Status In Patients With Pulmonary Arterial Hypertension

2010 · Marko A. Mychaskiw, Lie-Ju Hwang, et al. · American Journal of Respiratory and Critical Care Medicine · 1

Works count: 28

Citation count: 630

H-index: 13

I10-index: 15